Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1037389 NEW YORK, NY
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,975,368
+$2,755,408 QoQ
Shares Held
3,834,312
+79.2% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 209 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. ALLO ranks #62 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in ALLO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,975,368 3,834,312
2026-03-31 $5,219,960 2,139,328
2025-12-31 $2,996,305 2,187,084
2025-09-30 $3,588,326 2,893,812
2025-06-30 $1,887,113 1,670,012
2025-03-31 $2,272,782 1,556,700
2024-12-31 $1,181,172 554,541
2024-09-30 $1,797,625 642,009
2024-06-30 $4,072,735 1,747,955
2024-03-31 $1,774,143 396,900
2023-12-31 $1,472,260 458,648
2023-09-30 $95,993 30,282
2023-06-30 $1,251,943 251,900
2023-03-31 $2,117,778 428,700
2022-12-31 $2,768,229 440,100
2022-03-31 $8,879,517 974,700
2021-06-30 $18,370,752 704,400
2020-09-30 $3,163,869 83,900
2020-06-30 $1,079,064 25,200